Immune Design Corp. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 14 rows in 2016. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2016-10-01: Reporting owner Yurasov Sergey; Form 4; Security Employee Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2016-06-15: Reporting owner Kelley Susan L.; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2016-01-04: Reporting owner ter Meulen Jan Henrik; Form 4; Security Employee Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2016-01-04: Reporting owner Paya Carlos V; Form 4; Security Employee Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2016-10-01 | Yurasov Sergey Officer (Sr. VP, Clinic. Devel. & CMO) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +140,000 140,000 owned after | $7.58 exercise price | 2016-10-04 | |
| 2016-06-15 | Kelley Susan L. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +23,300 23,300 owned after | $10.10 exercise price | 2016-06-17 | |
| 2016-01-04 | ter Meulen Jan Henrik Officer (Chief Scientific Officer) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +60,000 60,000 owned after | $19.39 exercise price | 2016-01-06 | |
| 2016-01-04 | Paya Carlos V Director, Officer (President and CEO) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +175,000 175,000 owned after | $19.39 exercise price | 2016-01-06 | |
| 2016-01-04 | Kenney Richard T Officer (Chief Medical Officer) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,000 30,000 owned after | $19.39 exercise price | 2016-01-06 | |
| 2016-01-04 | Gombotz Wayne Officer (Chief Development Officer) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +60,000 60,000 owned after | $19.39 exercise price | 2016-01-06 | |
| 2016-01-04 | Brady Stephen R Officer (EVP, Strategy & Finance) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +75,000 75,000 owned after | $19.39 exercise price | 2016-01-06 | |
| 2016-01-04 | RINGO WILLIAM R Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,300 9,300 owned after | $19.39 exercise price | 2016-01-06 | |
| 2016-01-04 | Svennilson Peter Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,300 9,300 owned after | $19.39 exercise price | 2016-01-06 | |
| 2016-01-04 | PENHOET EDWARD Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,300 9,300 owned after | $19.39 exercise price | 2016-01-06 | |
| 2016-01-04 | COLEMAN LEWIS W Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,300 9,300 owned after | $19.39 exercise price | 2016-01-06 | |
| 2016-01-04 | BERGER FRANKLIN M Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,300 9,300 owned after | $19.39 exercise price | 2016-01-06 | |
| 2016-01-04 | BALTIMORE DAVID Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,300 9,300 owned after | $19.39 exercise price | 2016-01-06 | |
| 2016-01-04 | ATWOOD BRIAN G Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,300 9,300 owned after | $19.39 exercise price | 2016-01-06 |